Tabula Rasa HealthCare Inc (TRHC, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Tabula Rasa HealthCare Inc provides patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Tabula Rasa HealthCare Inc has a market cap of $643.260 million; its shares were traded at around $36.04 with a P/E ratio of 52.24 and P/S ratio of 4.81.
For the last quarter Tabula Rasa HealthCare Inc reported a revenue of $43.9 million, compared with the revenue of $27.31 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $134.5 million, an increase of 43% from last year.
The reported diluted earnings per share was 76 cents for the year. The Tabula Rasa HealthCare Inc had an operating margin of 3.87%, compared with the operating margin of 4.84% a year before. The 10-year historical median operating margin of Tabula Rasa HealthCare Inc is 3.87%. The profitability rank of the company is 5 (out of 10).
At the end of the fiscal year, Tabula Rasa HealthCare Inc has the cash and cash equivalents of $10.4 million, compared with $4.35 million in the previous year. The long term debt was $0.78 million, compared with $1.07 million in the previous year. The interest coverage to the debt is 7.6. Tabula Rasa HealthCare Inc has a financial strength rank of 5 (out of 10).
At the current stock price of $36.04, Tabula Rasa HealthCare Inc is traded at 142.7% premium to its historical median P/S valuation band of $14.85. The P/S ratio of the stock is 4.81, while the historical median P/S ratio is 1.98. The stock gained 149.43% during the past 12 months.
CEO Recent Trades:
- CEO Calvin H Knowlton sold 8,000 shares of TRHC stock on 03/07/2018 at the average price of $35.59. The price of the stock has increased by 1.26% since.
Directors and Officers Recent Trades:
- Director Bruce Luehrs sold 15,664 shares of TRHC stock on 03/09/2018 at the average price of $37.09. The price of the stock has decreased by 2.83% since.
- President Orsula V Knowlton sold 8,000 shares of TRHC stock on 03/07/2018 at the average price of $35.59. The price of the stock has increased by 1.26% since.
- Director Bruce Luehrs sold 3,115 shares of TRHC stock on 03/06/2018 at the average price of $36.03. The price of the stock has increased by 0.03% since.
- Director Bruce Luehrs sold 252,242 shares of TRHC stock on 02/22/2018 at the average price of $34.29. The price of the stock has increased by 5.1% since.
For the complete 20-year historical financial data of TRHC, click here.
